These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 22916723

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
    Hattori H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N.
    Neurosci Lett; 2005 Feb 10; 374(2):132-5. PubMed ID: 15644279
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB, Mlinac K, Ozretić D, Vladić A, Bognar SK.
    Coll Antropol; 2011 Jan 10; 35 Suppl 1():11-6. PubMed ID: 21648305
    [Abstract] [Full Text] [Related]

  • 6. CD24 as a genetic modifier of disease progression in multiple sclerosis in Argentinean patients.
    González SJ, Rojas JI, Redal MA, Patrucco L, Correale J, Argibay PF, Cristiano E.
    J Neurol Sci; 2011 Aug 15; 307(1-2):18-21. PubMed ID: 21641619
    [Abstract] [Full Text] [Related]

  • 7. Lack of association between monocyte protein-1 (MCP-1) -2518 A>G chemoattractant and C-C chemokine receptor 2 (CCR2) Val64Ile polymorphisms and multiple sclerosis in a Tunisian population.
    Messadi A, Fekih-Mrissa N, Kallel A, Bouguerra C, Sediri Y, Zaweli J, Laayouni S, Nciri B, Yedeas M, Mrissa R, Jemaa R, Kaabachi N, Gritli N.
    J Clin Neurosci; 2010 Oct 15; 17(10):1311-3. PubMed ID: 20637631
    [Abstract] [Full Text] [Related]

  • 8. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR, Reiche EM, Brum Souza DG, Frota Comini ER, Bobroff F, Morimoto HK, Ehara Watanabe MA, Carvalho De Oliveira J, Matsuo T, Lopes J, Donadi EA.
    Int J Mol Med; 2007 Sep 15; 20(3):337-44. PubMed ID: 17671738
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
    Stoevring B, Frederiksen JL, Christiansen M.
    Clin Chim Acta; 2007 Jan 15; 375(1-2):57-62. PubMed ID: 17010329
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
    Camiña-Tato M, Fernández M, Morcillo-Suárez C, Navarro A, Julià E, Edo MC, Montalban X, Comabella M.
    J Neuroimmunol; 2010 May 15; 222(1-2):70-5. PubMed ID: 20363033
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.